WESPAC Advisors SoCal LLC Has $6.30 Million Stake in UnitedHealth Group Inc (NYSE:UNH)

WESPAC Advisors SoCal LLC cut its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 32,153 shares of the healthcare conglomerate’s stock after selling 900 shares during the period. UnitedHealth Group accounts for about 3.7% of WESPAC Advisors SoCal LLC’s holdings, making the stock its 3rd biggest position. WESPAC Advisors SoCal LLC’s holdings in UnitedHealth Group were worth $6,297,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Blue Chip Partners Inc. purchased a new position in UnitedHealth Group in the 2nd quarter valued at $110,000. Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its stake in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after buying an additional 520 shares during the last quarter. BDO Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth $121,000. Finally, Acrospire Investment Management LLC raised its stake in shares of UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after buying an additional 400 shares during the last quarter. Institutional investors and hedge funds own 86.21% of the company’s stock.

In related news, CEO Larry C. Renfro sold 22,598 shares of UnitedHealth Group stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,853 shares of company stock valued at $9,980,908. Corporate insiders own 0.89% of the company’s stock.

Several brokerages recently weighed in on UNH. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price for the company in a research note on Saturday, January 20th. Argus boosted their target price on UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a report on Thursday, January 18th. Credit Suisse Group boosted their target price on UnitedHealth Group from $252.00 to $260.00 and gave the stock an “outperform” rating in a report on Wednesday, January 17th. Oppenheimer upped their price target on UnitedHealth Group from $260.00 to $240.00 and gave the stock an “outperform” rating in a report on Wednesday, January 17th. Finally, Cantor Fitzgerald upped their target price on UnitedHealth Group to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, January 17th. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and an average price target of $243.22.

UnitedHealth Group Inc (NYSE:UNH) traded up $0.13 on Wednesday, reaching $236.78. The company’s stock had a trading volume of 5,190,000 shares, compared to its average volume of 3,450,000. The firm has a market cap of $228,930.00, a price-to-earnings ratio of 22.11, a P/E/G ratio of 1.44 and a beta of 0.66. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70. UnitedHealth Group Inc has a 12-month low of $156.49 and a 12-month high of $250.79.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. UnitedHealth Group’s revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the company earned $2.11 EPS. equities research analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current year.

TRADEMARK VIOLATION WARNING: This report was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/01/31/wespac-advisors-socal-llc-has-6-30-million-holdings-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply